DALLAS SEMICONDUCTOR CORP
10-Q, 1995-11-13
SEMICONDUCTORS & RELATED DEVICES
Previous: SYNTHETECH INC, 10QSB, 1995-11-13
Next: LIBERTY EQUIPMENT INVESTORS LP 1984, 10-Q, 1995-11-13




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.  20549

                                    FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE 
    SECURITIES EXCHANGE ACT OF 1934
    For the quarterly period ended   October 1, 1995
                                     ---------------

                                       OR

[ ] TRANSITION REPORT  PURSUANT TO SECTION 13 OR 15(d) OF THE 
    SECURITIES EXCHANGE ACT OF 1934
    For the transition period from           to 
                                  ----------    ------------


                       DALLAS SEMICONDUCTOR CORPORATION     
           ------------------------------------------------------
           (Exact name of registrant as specified in its charter)

              Delaware                               75-1935715
              --------                               ----------
   (State or other jurisdiction of      (I.R.S. Employer Identification No.)
   incorporation or organization)       

        
           4401 South Beltwood Parkway, Dallas, Texas 75244-3292 
           -----------------------------------------------------
            (Address of principal executive offices)  (Zip Code)


      Registrant's telephone number, including area code:  (214) 450-0400
                                                           --------------

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.

                                               Yes    X       No 
                                                   -------       --------

Number of shares outstanding of the registrant's Common Stock as of 
November 5, 1995:  26,345,387.
                   ----------



<PAGE>  2            
                    DALLAS SEMICONDUCTOR CORPORATION
                           INDEX TO FORM 10-Q


PART I.     FINANCIAL INFORMATION
- -------     ---------------------
Item 1.     FINANCIAL STATEMENTS                                    Page No.
- -------     ------------------------------------------------------  --------
 Condensed Consolidated Statements of Income (Unaudited)
  Three and nine months ended October 1, 1995 and October 2, 1994 ....  3

 Condensed Consolidated Balance Sheets
  October 1, 1995 (Unaudited) and January 1, 1995 ....................  4
 
 Condensed Consolidated Statements of Cash Flows (Unaudited)  
  Nine months ended October 1, 1995 and October 2, 1994 ..............  5 

 Notes to Condensed Consolidated Financial Statements (Unaudited) ....  6
 
Item 2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
- -------     ----------------------------------------
            FINANCIAL CONDITION AND RESULTS OF OPERATIONS  ........ 7 - 8
            ----------------------------------------------    

PART II.    OTHER INFORMATION
- --------    ------------------
Items 1. through 6.  .................................................  9
- ------------------

SIGNATURE ............................................................ 10
- ---------

EXHIBIT 27.  ART. 5 FDS FOR 3RD QUARTER 10-Q ......................... 11
- --------------------------------------------


<PAGE> 3

PART I.     FINANCIAL INFORMATION

Item 1.     Financial Statements
- -------     --------------------


                        DALLAS SEMICONDUCTOR CORPORATION
                   CONDENSED CONSOLIDATED STATEMENTS OF INCOME

                                   (Unaudited)


                                        Three months         Nine months 
                                           ended                ended
                                      -----------------  ------------------
                                      Oct. 1,  Oct. 2,    Oct. 1,   Oct. 2,
(Thousands except per share amounts)   1995     1994       1995      1994
- ------------------------------------  -------  -------   --------  --------
Net sales                             $60,512  $45,201   $169,582  $133,425

Operating costs and expenses:           
 Cost of sales                         30,429   22,556     85,292    66,248
 Research and development               7,436    5,663     20,925    16,536
 Selling, general and administrative    9,292    6,596     25,934    19,456
                                      -------  -------   --------  --------
 Total costs and expenses              47,157   34,815    132,151   102,240 
                                      -------  -------   --------  --------
Operating income                       13,355   10,386     37,431    31,185
Interest income, net                      894      776      2,417     2,446
                                      -------  -------   --------  --------
Income before income taxes             14,249   11,162     39,848    33,631
Provision for income taxes              4,702    3,795     13,278    11,435 
                                      -------  -------   --------  --------
Net income                            $ 9,547  $ 7,367   $ 26,570  $ 22,196
                                      =======  =======   ========  ========
Net income per share                  $  0.34  $  0.27   $   0.96  $   0.81
                                      =======  =======   ========  ========
Weighted average common and common
equivalent shares outstanding          28,083   27,231     27,667    27,391
                                      =======  =======   ========  ========

Dividends declared per share          $ 0.025  $    --   $  0.075  $     --
                                      =======  =======   ========  ========

See accompanying notes.


<PAGE> 4 
                          DALLAS SEMICONDUCTOR CORPORATION
                        CONDENSED CONSOLIDATED BALANCE SHEETS

                                                    Oct. 1,     Jan. 1,
(Dollars in thousands except per share amounts)       1995        1995
- -----------------------------------------------   ----------  ----------
                                                  (unaudited)      
Assets

Current assets:
 Cash and cash investments                         $ 79,197    $ 64,520
 Accounts receivable, net                            32,794      28,330
 Inventories                                         43,179      40,453
 Deferred tax assets                                  2,645       2,561
 Other current assets                                 3,220       3,730
                                                   --------    --------
Total current assets                                161,035     139,594
 
Property, plant and equipment, at cost:
 Land                                                 6,325       5,400
 Building and improvements                           32,362      28,617 
 Machinery and equipment                            154,929     130,216
                                                   --------    --------
                                                    193,616     164,233
                                                   
Less accumulated depreciation                      (100,622)    (85,391)
                                                   --------    --------
   Property, plant and equipment, net                92,994      78,842

Other assets                                          4,300       2,791
                                                   --------    --------
                                                   $258,329    $221,227
                                                   --------    --------

Liabilities and Stockholders' Equity

Current liabilities: 
 Accounts payable                                  $ 19,072    $ 14,827
 Accrued salaries and benefits                        6,934       5,328
 Accrued taxes other than income                      1,881       2,486
 Other accrued liabilities                            3,500       2,712
 Income taxes payable                                 1,334       1,121
                                                   ---------   --------
 Total current liabilities                         $ 32,721    $ 26,474

Stockholders' equity:
 Preferred stock, $0.10 par value;
    5,000,000 shares authorized; no shares 
    issued and outstanding                              ---         ---
 Common stock, $0.02 par value; 40,000,000
    shares authorized; issued:
    26,380,367 shares at October 1, 1995, and
    25,575,586 shares at January 1, 1995                528         511
 Additional paid-in capital                          85,374      80,562
 Retained earnings                                  140,581     115,962
 Treasury stock, shares at cost:
    55,625 shares at October 1, 1995, and
    153,900 shares at January 1, 1995                  (875)     (2,282)
                                                   ---------   --------
 Total stockholders' equity                         225,608     194,753
                                                   ---------   --------
                                                   $258,329    $221,227
                                                   ---------   --------

See accompanying notes.


<PAGE>  5

                     DALLAS SEMICONDUCTOR CORPORATION
              CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                (Unaudited)

                                                    Nine Months Ended
                                                  ---------------------
                                                    Oct. 1,     Oct. 2,
(Thousands)                                          1995         1994
- -----------------------------------------------   ---------   ---------
Cash flows from operating activities:
Net income                                         $ 26,570    $ 22,196
Adjustments to reconcile net income to net
 cash provided by operating activities:
 Depreciation and amortization                       15,231      10,644
 Deferred tax benefit                                   (84)     (1,359)
 Increase in receivables                             (4,464)     (4,726)  
 Increase in inventories                             (2,726)     (5,364)
 Decrease (increase) in other current assets          1,368        (200)
 Increase in accounts payable                         4,245       4,647
 Increase (decrease) in accrued salaries & benefits   1,606        (465)
 Decrease in accrued taxes other than income           (605)       (167)
 Increase in other accrued liabilities                  788         100
 Increase in income taxes payable                     2,156         656
                                                   --------    --------
Net cash provided by operating activities            44,085      25,962
                                                   --------    --------

Cash flows from investing activities:
Additions to property, plant and equipment          (29,383)    (39,478)
Increase in other assets                             (1,509)       (792)
                                                   --------    --------
Net cash used by investing activities               (30,892)    (40,270)
                                                   --------    --------
Cash flows from financing activities:
Proceeds from issuance of stock                     
 upon exercise  of stock options                      3,855         803    
Purchase of treasury stock                             (420)       (482)
Dividend paid to shareholders                        (1,951)         --
                                                   --------    --------
Net cash provided by financing activities             1,484         321  
                                                   --------    --------
Net increase (decrease) in cash 
 and cash investments                                14,677     (13,987)
Cash and cash investments at beginning 
 of the period                                       64,520      76,273
                                                   --------    --------
Cash and cash investments at end of period         $ 79,197    $ 62,286
                                                   ========    ========
Cash payments for:
  Income taxes                                     $ 11,206    $ 12,141
 
Supplementary schedule of non-cash financing activities:
  Reduction of income tax payable and increase 
  in paid-in capital resulting from the tax 
  benefit of stock option exercises                $  1,943    $    682

See accompanying notes.


<PAGE> 6
                         DALLAS SEMICONDUCTOR CORPORATION
                 NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                    (Unaudited)
    
1. INTERIM ACCOUNTING POLICY
The accompanying condensed consolidated financial statements have not
been audited by independent auditors, except for the balance sheet as
of January 1, 1995. In the opinion of the Company's management, the
accompanying financial statements reflect all adjustments (consisting only
of normal recurring accruals) necessary to present fairly the Company's
financial position at October 1, 1995 and January 1, 1995, and results of
operations and cash flows for the periods presented.

Certain footnote information has been condensed or omitted from these
financial statements. Therefore, these financial statements should be read
in conjunction with the financial statements and related notes included in
the Company's 1994 Annual Report, which statements and notes were
incorporated by reference in the Company's Annual Report on Form 10-K for
the year ended January 1, 1995. Results of operations for the three and nine
months ended October 1, 1995 are not necessarily indicative of results to be
expected for the full year.

The difference between primary and fully diluted net income per share 
was not material in any period.


                                               Oct. 1,        Jan. 1,
2. INVENTORIES (in thousands)                   1995           1995
                                              --------       --------
Raw materials                                 $  5,962       $  5,596
Work-in-process                                 26,993         23,727
Finished goods                                  10,224         11,130
                                              --------       --------
                                              $ 43,179       $ 40,453
                                              ========       ========

Inventories are stated at the lower of standard cost, which approximates 
actual cost (first-in, first-out), or market.
 

3.  INCOME TAXES
The provision for income taxes includes estimated federal and state income 
taxes at statutory rates and a deferred tax benefit for the three and nine 
months ended October 1, 1995 of $750,000 and $84,000, respectively. The 
Company's effective tax rate was 33% in the three months ended October 1, 1995 
and 33.3% in the nine months ended October 1, 1995, decreasing from 34.0% for 
the same periods in 1994. This decrease was a result of changes in anticipated
differences between income for financial statement purposes and taxable income 
for the different periods.


<PAGE>  7
DALLAS SEMICONDUCTOR CORPORATION


Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF
         FINANCIAL CONDITION AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS
- ---------------------
Net sales for the third quarter of 1995 were $60,512,000, an increase of 
34% over the same period in 1994. The Company's revenue growth is supported 
by increased unit sales of new and existing products in several product 
families, including, Microcontrollers, Timekeeping, System Extension, 
NV SRAMs, Telecommunications and Silicon Timed Circuits.

Gross margins remained relatively constant at 50% for the third quarter and 
the first nine months of 1995 and 1994. 

Research and development ("R&D") expenses for the third quarter of
1995 increased 31% over the same period in 1994. The increase resulted
primarily from increased personnel costs due to increased headcount. 
R&D expenses as a percent of sales decreased to 12% from 13% for the 
three month period ended October 1, 1995 and October 2, 1994, respectively. 
For the first nine months of 1995 and 1994, R&D expenses as a percent 
of sales have remained constant at 12%.

Selling, general and administrative ("SG&A") expenses for the third 
quarter of 1995 increased 41% compared with the third quarter of 1994. 
In the first nine months of 1995, SG&A expenses increased 33% over the same 
period in 1994. SG&A expenses as a percent of net sales remained constant 
at 15% for the three and nine month periods ended October 1, 1995 and 
October 2, 1994. The increase in SG&A expenses resulted primarily from 
increased sales commission amounts due to higher net sales, increased 
personnel costs and increased advertising expenditures.

Operating income increased 29% and 20% for the third quarter of 1995 and 
the first nine months of 1995 over the same periods in 1994, respectively. 
Operating income as a percent of sales decreased to 22% for the three 
and nine month periods ended October 1, 1995 from 23% for the same periods
ended October 2, 1994. The decrease in both periods resulted from higher
operating expenses as a percent of net sales.

Net interest income for the third quarter of 1995 increased by $118,000 over
the same period in 1994, due primarily from higher average cash balances for
the three month period. Net interest income decreased by $29,000 during the 
first nine months of 1995 over the same period in 1994, due primarily from
lower average cash balances for the nine month period. Changes in interest 
rates will continue to affect interest income as will any substantial change
in the amount of the Company's cash and cash investments or borrowings.

The provision for income taxes includes estimated federal and state income 
taxes at statutory rates and a deferred tax benefit for the three and nine 
month periods ended October 1, 1995 of $750,000 and $84,000, respectively. 
The Company's effective tax rate was 33% for the third quarter and 33.3% for 
the first nine months of 1995, decreasing from 34.0% for the same periods in 
1994. This decrease was a result of changes in anticipated differences between 
income for financial statement purposes and taxable income for the different 
periods.

<PAGE>  8

A number of uncertainties exist that may influence the Company's future 
operating results, including general economic conditions, changes in 
conditions affecting original equipment manufacturers, competition (including 
alternative technologies), the Company's success in developing new products 
and process technologies, market acceptance of the Company's new products, 
the ability of the Company to continue diversifying its product line, 
manufacturing performance, availability and price fluctuations of raw 
materials, and other factors.

FINANCIAL CONDITION
- -------------------
Cash and cash investments were $79.2 million at the end of the third quarter 
of 1995, compared with $64.5 million at the end of fiscal year 1994. The 
Company continued investing in financial instruments having maturities in 
excess of one year in order to obtain yields higher than those available in 
the short-term market.

Gross capital additions were $29.4 million in the first nine months of 1995, 
compared with $39.5 million in the same period of 1994. The decrease is 
primarily the result of construction in progress on the wafer fabrication 
facility during the first nine months of 1994.

Estimated capital expenditures of $43 million in 1995, including year-to-date 
building purchases of $2.2 million, are expected primarily for wafer 
fabrication, manufacturing and test equipment, and computer hardware and 
software.

In 1994 the board of directors authorized the purchase from time-to-time,
depending on market conditions, of up to 500,000 shares of the Company's 
common stock. As of October 1, 1995, a total of 180,000 shares, at an 
aggregate purchase price of $2,703,000 have been purchased pursuant to this 
stock repurchase program. 

On August 1, 1995 a $0.025 dividend was declared on each outstanding share of 
common stock, payable on September 1, 1995, to shareholders of record on
August 15, 1995 totaling $657,000. Cumulative dividends paid through October 1, 
1995 total $1,951,000. On October 24, 1995 a $0.025 dividend was declared on 
each outstanding share of common stock, payable on December 1, 1995, to 
shareholders on record on November 15, 1995.

The Company had no long-term debt at the end of the third quarter of 1995 or 
at the end of fiscal 1994.

<PAGE>  9
DALLAS SEMICONDUCTOR CORPORATION

PART II. OTHER INFORMATION
- --------------------------
Items 1.- 5.
- ------------   
 Not applicable.

Item 6. Exhibits and Reports on Form 8-K
- -----------------------------------------
  (a)    Exhibit 27 - Financial Data Schedule
         ------------------------------------
            None.
  (b)    Reports on Form 8-K
         -------------------
            No reports on Form 8-K were filed during the period
            for which this report is filed.

<PAGE>  10
DALLAS SEMICONDUCTOR CORPORATION

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned, thereunto duly authorized.

DALLAS SEMICONDUCTOR CORPORATION


By:       /s/ Alan P. Hale
         -----------------
          Alan P. Hale
          Vice President, Finance
                     
Date:    November 16, 1995
         -----------------

<PAGE>  11



<TABLE> <S> <C>

<ARTICLE>             5
<MULTIPLIER>          1,000
       
<S>                                        <C>
<PERIOD-TYPE>                           9-MOS
<FISCAL-YEAR-END>                 DEC-31-1995
<PERIOD-END>                      OCT-01-1995
<CASH>                                 79,197
<SECURITIES>                                0
<RECEIVABLES>                          32,794
<ALLOWANCES>                                0
<INVENTORY>                            43,179
<CURRENT-ASSETS>                      161,035
<PP&E>                                193,616
<DEPRECIATION>                        100,622
<TOTAL-ASSETS>                        258,329
<CURRENT-LIABILITIES>                  32,721
<BONDS>                                     0
<COMMON>                                  528
                       0
                                 0
<OTHER-SE>                            225,608
<TOTAL-LIABILITY-AND-EQUITY>          258,329
<SALES>                               169,582
<TOTAL-REVENUES>                      169,582
<CGS>                                  85,292
<TOTAL-COSTS>                         132,151
<OTHER-EXPENSES>                            0
<LOSS-PROVISION>                            0
<INTEREST-EXPENSE>                          0
<INCOME-PRETAX>                        39,848
<INCOME-TAX>                           13,278
<INCOME-CONTINUING>                         0
<DISCONTINUED>                              0
<EXTRAORDINARY>                             0
<CHANGES>                                   0
<NET-INCOME>                           26,570
<EPS-PRIMARY>                            0.96
<EPS-DILUTED>                               0
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission